Literature DB >> 18534288

Atenolol in combination with epinephrine improves the initial outcome of cardiopulmonary resuscitation in a swine model of ventricular fibrillation.

Eleni Bassiakou1, Theodoros Xanthos, Eleni Koudouna, Sotirios Goulas, Vassiliki Prapa, Dimitrios Papadimitriou, George Rokas, Lila Papadimitriou.   

Abstract

STUDY
OBJECTIVES: The aim of the present study was to assess whether a beta-adrenergic blocking agent such as atenolol, administered during cardiopulmonary resuscitation, would improve initial resuscitation success.
METHODS: Ventricular fibrillation was induced in 20 Landrace/Large White piglets, which were left untreated for 8 minutes before attempted resuscitation with precordial compression, mechanical ventilation, and electrical defibrillation. Animals were randomized into 2 groups (10 animals each) to receive saline as placebo (20 mL dilution, bolus) + epinephrine (0.02 mg/kg) (group A) or atenolol (0.05 mg/kg per 20 mL dilution, bolus) + epinephrine (0.02 mg/kg) (group B) during cardiopulmonary resuscitation. Electrical defibrillation was attempted after 10 minutes of ventricular fibrillation.
RESULTS: Nine animals in group B restored spontaneous circulation in comparison to only 4 in group A. Aortic systolic and diastolic pressures as well as coronary perfusion pressure were significantly increased during cardiopulmonary resuscitation in group B. Furthermore, postresuscitation heart rate of the atenolol-treated group was significantly decreased.
CONCLUSIONS: A beta-adrenergic blocking agent, when administered during cardiopulmonary resuscitation, significantly improves initial resuscitation success and increases blood and coronary perfusion pressures during cardiopulmonary resuscitation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18534288     DOI: 10.1016/j.ajem.2007.09.010

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  6 in total

Review 1.  Novelties in pharmacological management of cardiopulmonary resuscitation.

Authors:  Jason A Bartos; Demetris Yannopoulos
Journal:  Curr Opin Crit Care       Date:  2013-10       Impact factor: 3.687

2.  Does prearrest adrenergic integrity affect pressor response? A comparison of epinephrine and vasopressin in a spontaneous ventricular fibrillation swine model.

Authors:  Scott T Youngquist; Atman Shah; Christian McClung; Joseph L Thomas; John P Rosborough; James T Niemann
Journal:  Resuscitation       Date:  2010-11-03       Impact factor: 5.262

3.  Effects of prehospital epinephrine during out-of-hospital cardiac arrest with initial non-shockable rhythm: an observational cohort study.

Authors:  Yoshikazu Goto; Tetsuo Maeda; Yumiko Goto
Journal:  Crit Care       Date:  2013-09-03       Impact factor: 9.097

4.  Esmolol for cardioprotection during resuscitation with adrenaline in an ischaemic porcine cardiac arrest model.

Authors:  Hilde Karlsen; Harald Arne Bergan; Per Steinar Halvorsen; Kjetil Sunde; Eirik Qvigstad; Geir Øystein Andersen; Jan Frederik Bugge; Theresa Mariero Olasveengen
Journal:  Intensive Care Med Exp       Date:  2019-12-04

5.  Prognostic Factors for Re-Arrest with Shockable Rhythm during Target Temperature Management in Out-Of-Hospital Shockable Cardiac Arrest Patients.

Authors:  Seung Mok Ryoo; Dong Hun Lee; Byung Kook Lee; Chun Song Youn; Youn-Jung Kim; Su Jin Kim; Yong Hwan Kim; Won Young Kim
Journal:  J Clin Med       Date:  2019-09-01       Impact factor: 4.241

6.  The first case series analysis on efficacy of esmolol injection for in-hospital cardiac arrest patients with refractory shockable rhythms in China.

Authors:  Rui Lian; Guochao Zhang; Shengtao Yan; Lichao Sun; Wen Gao; Jianping Yang; Guonan Li; Rihong Huang; Xiaojie Wang; Renyang Liu; Guangqing Cao; Yong Wang; Guoqiang Zhang
Journal:  Front Pharmacol       Date:  2022-09-30       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.